First of all I would like to mention that I am a PhD student in a Bio-Engineering department and this answer contains information about the issue from that perspective. When I have started to my PhD I was thinking of pursuing an academic career in my field and ...
European doctorate in biotechnology: Added value for european academia and industryBiotechnologyEuropean doctoratePhDpostgraduate coursesIt has long been recognized that educational programs and degrees are not equivalent across Europe. Add to this the fact that Europe consists of many different cultures ...
Induction to senior-level heads from driving in general prescription and biotechnology affiliations Receptiveness to new and invigorating affiliations prepared for affiliations and permitting open entrances in the U.S., Europe and Asia Immense structures association freedoms to meet diverse U.S., European...
London. He joined BMI after completing a PhD in energy systems within an energy policy and economics think tank and has used his broader background in energy research, including several years in consultancy and training in technical analysis, to build out new energy research themes across the ...
Albany Molecular Research (AMRI) and Cubist Pharmaceuticals. He has also provided consulting services to a variety of academic programs, biotechnology companies and international development agencies. He holds a B.S. degree from Defiance College and M.A. and Ph.D. degrees from Harvard University. ...
medical cannabis community. As someone who comes from traditional pharma and biotechnology industries, heading up a clinical study in the medical cannabis realm has been a significantly different, eye-opening and informative experience that reinforces the dire need for mainstream, medical cannabis ...
Cho, PhD; Ryo Shohara; Anna Schissel, MBioethics; Drummond Rennie, MD JAMA Commentary Conflicts of Interest in Biomedical Research David Korn, MD JAMA Continuing Medical Education November 1, 2000 JAMA Abstract Context A growing number of academic researchers receive industry funding for clinical ...
strategy consulting firm for six years, where he led the Life Sciences M&A Practice. Earlier, he worked as a VP of Strategic Marketing and a BU Lead at an American medical technology company. He also served as the SVP Marketing & Sales for a startup biotechnology company which went public....
al25described data on 63 drugs approved between 2014 and 2018 using data extracted from audited financial reports. This method may overrepresent smaller public biotechnology firms for which development costs for individual products may be material to their valuation and itemized in their financial ...
BioSciencesCorp is a provider of end-to-end biologics and cell therapy manufacturing operation partnering with ambitious biotechnology companies to bring programs though cGMP development to market. BioSciencesCorp...